• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Jan 26;12:828887.
doi: 10.3389/fimmu.2021.828887. eCollection 2021.
A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice


Liqiong Song[SUP] 1 [/SUP], Yuanming Huang[SUP] 1 [/SUP], Guoxing Liu[SUP] 2 3 [/SUP], Xianping Li[SUP] 1 [/SUP], Yuchun Xiao[SUP] 1 [/SUP], Chang Liu[SUP] 2 [/SUP], Yue Zhang[SUP] 2 [/SUP], Jintong Li[SUP] 4 [/SUP], Jianguo Xu[SUP] 1 [/SUP], Shan Lu[SUP] 1 [/SUP], Zhihong Ren[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Objective: Probiotics can modulate immune responses to resist influenza infection. This study aims to evaluate the anti-viral efficacy of B. dorei.
Methods: C57BL/6J mice were infected with influenza virus together with treatment of PBS vehicle, B. dorei, or oseltamivir respectively. Anti-influenza potency of B. dorei and the underlying mechanism were determined by measuring survival rate, lung viral load and pathology, gene expression and production of cytokines and chemokines, and analysis of gut microbiota.
Results: Administration of B. dorei increased (by 30%) the survival of influenza-infected mice, and improved their weight loss, lung pathology, lung index, and colon length compared to the vehicle control group. B. dorei treatment reduced (by 61%) the viral load of lung tissue and increased expression of type 1 interferon more rapidly at day 3 postinfection. At day 7 postinfection, B. dorei-treated mice showed lower local (lung) and systemic (serum) levels of interferon and several proinflammatory cytokines or chemokines (IL-1β, IL-6, TNF-α, IL-10, MCP-1 and IP-10) with a efficacy comparable to oseltamivi treatment. B. dorei treatment also altered gut microbiota as indicated by increased levels of Bacteroides, Prevotella, and Lactobacillus and decreased levels of Escherichia, Shigella, and Parabacteroides.
Conclusion: B. dorei has anti-influenza effect. Its working mechanisms involve promoting earlier interferon expression and down-regulating both local and systemic inflammatory response. B. dorei changes the composition of gut microbiota, which may also contribute to its beneficial effects.

Keywords: B. dorei; cytokines; gut microbiota; influenza; interferon.
 
Back
Top